The protocol at a glance
There is no label and no trial, so there is no schedule to report.
| Item | What the sources show |
|---|---|
| Human dose | Not established |
| Studied in | No published studies found |
Searches of PubMed and ClinicalTrials.gov on 5 Nov 2026 returned nothing for Adalank. Seller pages disagree on what the change is (an adamantane group, or an N-acetyl and amide cap), so the exact molecule is unclear.
Community notes copy Selank's ranges for Adalank. That is an assumption, not an observation from studies.
What people say they do, collected from community discussions. Not tested in a trial; shown so you can compare it with the evidence above.
Mixing
No mixing table here: this one is used as a capsule, nasal spray or skin product, or has no human amount to calculate from. The general mixing calculator works for any vial.
What the trials found
There are no results to show. What the searches found:
Searches run 5 Nov 2026. Selank's own label and studies do not transfer to Adalank.
Side effects
- No safety data exists for Adalank.
- Do not assume Selank's label safety list applies to it.
How it works
Unknown
Sellers say the change helps it reach the brain and last longer. No study backs this.
Sources
- PubMed search by name, run 5 Nov 2026: 0 results for Adalank
- ClinicalTrials.gov search by intervention name, run 5 Nov 2026: 0 results
- Seller listings (peptide-db.com, peptidedeck.com), used only to show their structure claims conflict; not scientific sources
- RLS (rlsnet.ru) Selank entry (the parent drug)